Top Markets
Coin of the day
Mabion S.A. Mabion S.A.

Mabion S.A.

MAB
Rang in aandelen #27034
Mabion S.A. is a Polish biopharmaceutical firm dedicated to pioneering the... Mabion S.A. is a Polish biopharmaceutical firm dedicated to pioneering the development of biological drugs, primarily leveraging monoclonal antibody technology. The company oversees the full spectrum from research and development to the manufacturing and commercialization of therapies designed to combat a wide range of diseases, including neoplastic (cancer), autoimmune, metabolic, and neurological disorders. Key products in its portfolio include MabionCD20 and MabionHER2. Established in 2007, Mabion S.A. maintains its headquarters in Konstantynów Lódzki, Poland.
Aandeelprijs
$2.21
Marktkapitalisatie
$35.76M
Verandering (1 dag)
2.88%
Verandering (1 jaar)
-15.27%
Land
PL
Handel Mabion S.A. (MAB)

Categorie

Koersgeschiedenis voor Mabion S.A. (MAB)
Hoogste slotkoers: $2.13 op 2026-08-01

Laagste slotkoers: $4.20 op 2010-08-01
Koersgeschiedenis van Mabion S.A. van 2010 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 12.10%
2025 -19.31%
2024 -48.95%
2023 -2.07%
2022 -70.98%
2021 195.71%
2020 -72.42%
2019 -11.04%
2018 -20.35%
2017 62.87%
2016 57.30%
2015 6.33%
2014 -9.21%
2013 146.12%
2012 58.68%
2011 -42.39%
2010 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$120.74 -14.98%
AU
$759.53 6.72%
CH